Nature·4 min read·hard
Gene mutant dosage is associated with prognosis and metastatic tropism in 60,000 clinical cancer samples
C
Calonaci, Nicola
✦AI Summary
Researchers have developed a computational framework to analyze 'gene mutant dosage' (GMD) in cancer samples, identifying 46 biomarkers that predict patient survival and metastatic behavior. This method provides deeper insights into tumor evolution than traditional binary mutation models.
Why it matters
Improved understanding of genomic drivers in cancer can lead to more precise prognostic tools and personalized treatment strategies for patients.
Nature Genetics ( 2026 ) Cite this article
sciencehealth
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in